Oramed Pharmaceuticals Inc. | Balance Sheet
Fiscal year is September-August. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
8,491.20
21,306.00
17,245.00
31,032.00
20,097.00
30,463
Total Accounts Receivable
153.00
408.00
-
-
41.00
-
Other Current Assets
-
64.00
127.00
198.00
159.00
574
Total Current Assets
8,644.30
21,778.00
17,372.00
31,230.00
20,297.00
31,037
Net Property, Plant & Equipment
5.80
14.00
11.00
16.00
18.00
17
Total Investments and Advances
2.60
3.00
8,962.00
11,573.00
18,383.00
16,327
Other Assets
7.50
7.00
9.00
11.00
14.00
16
Total Assets
8,660.20
21,802.00
26,354.00
42,830.00
38,712.00
47,397
Accounts Payable
439.50
-
-
1,459.00
2,716.00
Other Current Liabilities
58.70
973.00
1,489.00
2,162.00
2,449.00
Total Current Liabilities
498.20
973.00
1,489.00
3,621.00
5,165.00
Provision for Risks & Charges
31.20
36.00
37.00
25.00
29.00
Other Liabilities
-
-
-
12,994.00
14,280.00
Total Liabilities
529.40
1,009.00
1,526.00
16,640.00
19,474.00
Common Equity (Total)
8,130.80
20,793.00
24,828.00
26,190.00
19,238.00
Total Shareholders' Equity
8,130.80
20,793.00
24,828.00
26,190.00
19,238.00
Total Equity
8,130.80
20,793.00
24,828.00
26,190.00
19,238.00
Liabilities & Shareholders' Equity
8,660.20
21,802.00
26,354.00
42,830.00
38,712.00
About Oramed Pharmaceuticals
View Profile
